Looks like someone's New Year's resolution was to update the Resverlogix/Apabetalone ClinicalTrials.gov listings.

Phase 3 BETonMACE updated January 15, 2019. Status changed from "recruiting" to "active, not recruiting" and anticipated primary and study completion updated to June 2019:

https://clinicaltrials.gov/ct2/show/NCT02586155

Phase 1/2 Renal trial updated January 21, 2019. Anticipated start date changed from December 15, 2018 to September 15, 2019. Anticipated primary and study completion remain unchanged as March 15, 2020:

https://clinicaltrials.gov/ct2/show/NCT03160430

Phase 1 Pulmonary Arterial Hypertension trial updated January 23, 2019. Anticipated start date changed from November 2018 to February 2019. Title changed to now include "APPRoAcH-p" and now reads "Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study (APPRoAcH-p)." Anticipated primary and study completion updated to December 2020. Contacts/locations seem to be updated too: 

https://clinicaltrials.gov/ct2/show/NCT03655704